𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of high dose raloxifene in selected patients with advanced breast carcinoma

✍ Scribed by William Gradishar; Joan Glusman; Yili Lu; Charles Vogel; Fredric J. Cohen; George W. Sledge Jr.


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
78 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND. An earlier trial of raloxifene, conducted in women with metastatic breast carcinoma who initially had responded to tamoxifen and subsequently developed disease progression, suggested no antitumor activity for raloxifene in tamoxifen-refractory disease. However, preclinical studies and preliminary clinical data in healthy women suggest that raloxifene antagonizes growth of estrogendependent neoplasia.


πŸ“œ SIMILAR VOLUMES


A Phase II trial of high dose epirubicin
✍ Kathy D. Miller; Nikhil Munshi; David Loesch; Lawrence H. Einhorn; George W. Sle πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis

High response rate with a lower dose of
✍ Abdel G. Maiche; Antti P. Jekunen; Jaana Kaleva-Kerola; Guillermo Blanco Sequeir πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 2 views

## BACKGROUND. Paclitaxel has been found to be efficacious in the treatment of breast carcinoma either when administered alone or in combination with other anticancer agents. Synergistic interaction between paclitaxel and cisplatin has been demonstrated in vitro. ## METHODS. Thirty-two patients w

Effect of high-dose thymidine infusions
✍ D. W. Kufe; M. M. Wick; S. Moschella; P. Major πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 381 KB πŸ‘ 1 views

The antitumor effect of thymidine has been demonstrated in patients with leukemia and lymphoma. This report summarizes the treatment of three patients with mycosis fungoides, a chronic T-cell lymphoma. Four cour.ses of thymidine (75 glm'lday) were administered by continuous infusion for 4-7 days. St